A wide patent portfolio
Guard Therapeutics holds three granted international patent families.
Taken together, these patents and patent applications cover the product as well as the medical use of RMC-035 (ROSgard) (and similar drug candidates) for the treatment of kidney injury and other diseases associated with oxidative stress.
